Literature DB >> 24169039

Separation and identification of underivatized plasma acylcarnitine isomers using liquid chromatography-tandem mass spectrometry for the differential diagnosis of organic acidemias and fatty acid oxidation defects.

Minzhi Peng1, Xiefan Fang, Yonglan Huang, Yanna Cai, Cuili Liang, Ruizhu Lin, Li Liu.   

Abstract

A simple HPLC-MS/MS method has been established to separate and identify underivatized acylcarnitine isomers. Human plasma samples were deproteinized and concentrated. Acylcarnitines were separated on a reverse phase column and detected with triple quadrupole linear ion trap mass spectrometry. Deuterium-labeled internal standards were used for quantitation. To identify acylcarnitines without pure standards, information-dependent acquisition linking to enhanced product ion scan mode was used. 112 acylcarnitines, including stereoisomers, were found in samples of patients. Dicarboxylic acylcarnitines, such as methylmalonylcarnitine and glutarylcarnitine, were detected with high sensitivity. Three stereoisomers of (R,S)2-methyl-3-hydroxy butyrylcarnitine were detected in samples of patients with β-ketothiolase deficiency. Validation results revealed excellent precision and accuracy of the method. In general the within- and between-run coefficients of variation (CV%) were less than 15%, and recoveries were in the range of 92.7-117.5%. In addition, the reference intervals of acylcarnitines for children aged 3-day to13-year old were established. Using the new method and reference intervals, we have correctly diagnosed 49 patients with fatty acid oxidation defects or organic acidemias in 176 high-risk patients.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Acylcarnitine; LC–MS/MS; Plasma; Product ion spectrum; Stereoisomer

Mesh:

Substances:

Year:  2013        PMID: 24169039     DOI: 10.1016/j.chroma.2013.10.036

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  9 in total

1.  Mass Spectral Library of Acylcarnitines Derived from Human Urine.

Authors:  Xinjian Yan; Sanford P Markey; Ramesh Marupaka; Qian Dong; Brian T Cooper; Yuri A Mirokhin; William E Wallace; Stephen E Stein
Journal:  Anal Chem       Date:  2020-04-23       Impact factor: 6.986

2.  A HILIC-MS/MS method development and validation for the quantitation of 13 acylcarnitines in human serum.

Authors:  Thomas Meikopoulos; Olga Deda; Efstratios Karagiannidis; Georgios Sianos; Georgios Theodoridis; Helen Gika
Journal:  Anal Bioanal Chem       Date:  2022-02-17       Impact factor: 4.142

3.  Quantitation of Urinary Acylcarnitines by DMS-MS/MS Uncovers the Effects of Total Body Irradiation in Cancer Patients.

Authors:  Nicholas B Vera; Stephen L Coy; Evagelia C Laiakis; Albert J Fornace; Michelle Clasquin; Christopher A Barker; Jeffrey A Pfefferkorn; Paul Vouros
Journal:  J Am Soc Mass Spectrom       Date:  2020-01-28       Impact factor: 3.109

4.  An LC-MS/MS method to quantify acylcarnitine species including isomeric and odd-numbered forms in plasma and tissues.

Authors:  Pieter Giesbertz; Josef Ecker; Alexander Haag; Britta Spanier; Hannelore Daniel
Journal:  J Lipid Res       Date:  2015-08-03       Impact factor: 5.922

5.  Metabolomic profiles of arsenic (+3 oxidation state) methyltransferase knockout mice: effect of sex and arsenic exposure.

Authors:  Madelyn C Huang; Christelle Douillet; Mingming Su; Kejun Zhou; Tao Wu; Wenlian Chen; Joseph A Galanko; Zuzana Drobná; R Jesse Saunders; Elizabeth Martin; Rebecca C Fry; Wei Jia; Miroslav Stýblo
Journal:  Arch Toxicol       Date:  2016-02-16       Impact factor: 5.153

6.  Quantitative acylcarnitine determination by UHPLC-MS/MS--Going beyond tandem MS acylcarnitine "profiles".

Authors:  Paul E Minkler; Maria S K Stoll; Stephen T Ingalls; Janos Kerner; Charles L Hoppel
Journal:  Mol Genet Metab       Date:  2015-10-08       Impact factor: 4.797

7.  Enhanced acylcarnitine annotation in high-resolution mass spectrometry data: fragmentation analysis for the classification and annotation of acylcarnitines.

Authors:  Justin J J van der Hooft; Lars Ridder; Michael P Barrett; Karl E V Burgess
Journal:  Front Bioeng Biotechnol       Date:  2015-03-09

8.  Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson's Disease.

Authors:  Kuo-Hsuan Chang; Mei-Ling Cheng; Hsiang-Yu Tang; Cheng-Yu Huang; Hsiu-Chuan Wu; Chiung-Mei Chen
Journal:  Cells       Date:  2022-01-24       Impact factor: 6.600

9.  Laboratory analysis of acylcarnitines, 2020 update: a technical standard of the American College of Medical Genetics and Genomics (ACMG).

Authors:  Marcus J Miller; Kristina Cusmano-Ozog; Devin Oglesbee; Sarah Young
Journal:  Genet Med       Date:  2020-10-19       Impact factor: 8.822

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.